Following Sartorius AG?
Get the free weekly contract digest
The latest new contracts, like Sartorius AG’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Sartorius partners with Sensible Biotechnologies to enhance mRNA production capabilities globally.
Jul 09, 2025•12 months ago
Contract Type
partnership
BiotechnologyLife Science
Description
Sartorius Stedim Biotech and Sensible Biotechnologies have signed a Memorandum of Understanding to scale up Sensible's cell-based mRNA design platform. The partnership aims to enable clinical-grade production of mRNA by 2026 and expand production facilities from Slovakia to the US, UK, and Europe.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months